Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$487K Sell
16,898
-7,267
-30% -$162K ﹤0.01% 708
2026
Q1
$410K Buy
24,165
+4,918
+26% +$105K ﹤0.01% 785
2025
Q4
$494K Sell
19,247
-2,122
-10% -$48.8K ﹤0.01% 763
2025
Q3
$460K Sell
21,369
-335
-2% -$7.61K ﹤0.01% 812
2025
Q2
$477K Sell
21,704
-6,753
-24% -$148K ﹤0.01% 772
2025
Q1
$636K Sell
28,457
-12,830
-31% -$276K ﹤0.01% 663
2024
Q4
$712K Buy
41,287
+9,721
+31% +$151K ﹤0.01% 650
2024
Q3
$529K Buy
31,566
+8,778
+39% +$211K ﹤0.01% 800
2024
Q2
$652K Buy
22,788
+5,969
+35% +$180K ﹤0.01% 700
2024
Q1
$642K Sell
16,819
-1,049
-6% -$39.7K ﹤0.01% 794
2023
Q4
$664K Buy
+17,868
New +$600K ﹤0.01% 766
2022
Q2
Sell
-17,848
Closed -$917K 1098
2022
Q1
$917K Sell
17,848
-29,340
-62% -$1.26M ﹤0.01% 975
2021
Q4
$2.38M Buy
47,188
+18,394
+64% +$1.03M 0.01% 830
2021
Q3
$1.61M Buy
+28,794
New +$1.59M 0.01% 852

Other funds holding PGNY

Aviva's PGNY Position: Q2 2026 in Review

Aviva reduced its Progyny (PGNY) stake by 30% in Q2 2026, selling an estimated $162K and leaving 16,898 shares worth $487K. The position accounts for ﹤0.01% of the portfolio, ranked #708.

Aviva first reported a position in PGNY in Q3 2021 and has held it in 14 quarters since. The position peaked at $2.38M in Q4 2021. 311 funds tracked by Wall St. Rank hold PGNY as of Q2 2026.

  • Aviva held 16,898 shares of Progyny worth $487K as of Q2 2026.
  • Aviva sold 7,267 Progyny shares in Q2 2026, an estimated $162K.
  • Progyny made up ﹤0.01% of Aviva's portfolio in Q2 2026, its #708 holding.
  • Aviva first reported a position in Progyny in Q3 2021 and has held it in 14 quarters since.
  • Aviva's Progyny position peaked at $2.38M in Q4 2021.
  • 311 funds tracked by Wall St. Rank held Progyny as of Q2 2026.

Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.